Non-small cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Stuttering
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
34
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Diabetic Neuralgia
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
36
|
|
0.030 |
None |
1.000 |
3 |
|
2019 |
2020 |
Intrauterine retardation
|
phenotype |
|
Pathologic Function
|
41
|
56
|
0.100 |
None |
|
0 |
1
|
|
|
Transformed migraine
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
43
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Morphine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Placental Insufficiency
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
45
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Fetal Alcohol Spectrum Disorders
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders
|
Disease or Syndrome; Congenital Abnormality
|
46
|
2
|
0.200 |
None |
1.000 |
2 |
|
2012 |
2013 |
Learning Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
46
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Smith-Magenis syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
47
|
8
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Overriding toe
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Anatomical Abnormality
|
47
|
13
|
0.100 |
None |
|
0 |
1
|
|
|
Clumsiness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Sign or Symptom
|
48
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Hyperextensible skin
|
phenotype |
|
Finding
|
50
|
11
|
0.100 |
None |
|
0 |
1
|
|
|
Acid reflux
|
phenotype |
|
Finding
|
50
|
58
|
0.100 |
None |
|
0 |
1
|
|
|
Impulsive character (finding)
|
phenotype |
|
Mental or Behavioral Dysfunction
|
52
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
59
|
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malformations of Cortical Development
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
60
|
5
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Large head (disorder)
|
phenotype |
|
Finding
|
64
|
116
|
0.100 |
None |
|
0 |
1
|
|
|
Depressive Disorder, Treatment-Resistant
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
66
|
19
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2017 |
Inattention
|
phenotype |
|
Mental or Behavioral Dysfunction
|
66
|
22
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Disruptive, Impulse Control, and Conduct Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
67
|
9
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2016 |
Alcohol withdrawal syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
67
|
6
|
0.020 |
None |
1.000 |
2 |
1
|
2009 |
2017 |
Mental impairment
|
disease |
|
Mental or Behavioral Dysfunction
|
67
|
14
|
0.110 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Coxa valga
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Finding
|
68
|
5
|
0.100 |
None |
|
0 |
1
|
|
|